{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:16:22Z","timestamp":1791000982990,"version":"4.1.0"},"reference-count":23,"publisher":"Society of Nuclear Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.2967\/jnumed.116.172221","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T22:40:17Z","timestamp":1464302417000},"page":"1505-1511","source":"Crossref","is-referenced-by-count":70,"title":["Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and\n                    <sup>68<\/sup>\n                    Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial"],"prefix":"10.2967","volume":"57","author":[{"given":"Caroline","family":"Bodet-Milin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Faivre-Chauvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Rauscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Cerato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Rohmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Couturier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Drui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Sharkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Barbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Kraeber-Bodere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2016,5,26]]},"reference":[{"key":"2021051712094136000_57.10.1505.1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1836"},{"key":"2021051712094136000_57.10.1505.2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0335"},{"key":"2021051712094136000_57.10.1505.3","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0342"},{"key":"2021051712094136000_57.10.1505.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.094771"},{"key":"2021051712094136000_57.10.1505.5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0938"},{"key":"2021051712094136000_57.10.1505.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.105940"},{"key":"2021051712094136000_57.10.1505.7","first-page":"1267","article-title":"Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA\/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer","volume":"34","author":"Peltier","year":"1993","journal-title":"J Nucl Med."},{"key":"2021051712094136000_57.10.1505.8","first-page":"1172","article-title":"Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA \u00d7 anti-DTPA-indium bispecific antibody","volume":"39","author":"Barbet","year":"1998","journal-title":"J Nucl Med."},{"key":"2021051712094136000_57.10.1505.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.056887"},{"key":"2021051712094136000_57.10.1505.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.089771"},{"key":"2021051712094136000_57.10.1505.11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0600982103"},{"key":"2021051712094136000_57.10.1505.12","first-page":"1678","article-title":"Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide","volume":"47","author":"McBride","year":"2006","journal-title":"J Nucl Med."},{"key":"2021051712094136000_57.10.1505.13","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0862"},{"key":"2021051712094136000_57.10.1505.14","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.376"},{"key":"2021051712094136000_57.10.1505.15","first-page":"1593","article-title":"Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer","volume":"41","author":"Schoffelen","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712094136000_57.10.1505.16","first-page":"247","article-title":"Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial","volume":"47","author":"Kraeber-Bod\u00e9r\u00e9","year":"2006","journal-title":"J Nucl Med."},{"key":"2021051712094136000_57.10.1505.17","first-page":"84","article-title":"Pharmacokinetics and dosimetry studies for optimization of pretargeted radioimmunotherapy in CEA expressing advanced lung cancer patient","volume":"2","author":"Bodet-Milin","year":"2015","journal-title":"Front Med (Lausanne)."},{"key":"2021051712094136000_57.10.1505.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.060418"},{"key":"2021051712094136000_57.10.1505.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.118612"},{"key":"2021051712094136000_57.10.1505.20","first-page":"354","article-title":"A universal pretargeting system for cancer detection and therapy using bispecific antibody","volume":"63","author":"Sharkey","year":"2003","journal-title":"Cancer Res."},{"key":"2021051712094136000_57.10.1505.21","doi-asserted-by":"publisher","DOI":"10.1186\/2197-7364-1-9"},{"key":"2021051712094136000_57.10.1505.22","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.12"},{"key":"2021051712094136000_57.10.1505.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.073239"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.116.172221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T16:09:35Z","timestamp":1621267775000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.116.172221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,26]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,3]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.2967\/jnumed.116.172221"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.116.172221","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,26]]}}}